Stay Awake

Add Info

Stay Awake Recall

Get an alert when a recall is issued.

Ask a Question

Questions & Answers

Add Info

Side Effects & Adverse Reactions

For occasional use only
_________________________________________________________________________________________________________________________________________________________

Caffeine warning: The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat.

Do not use

in children under 12 years
as a substitute for sleep

Stop use and ask a doctor if

fatigue or drowsiness persists or continues to recur.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use

in children under 12 years
as a substitute for sleep

Stop use and ask a doctor if

fatigue or drowsiness persists or continues to recur.

Add Info

Legal Issues

There is currently no legal information available for this drug.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

There are no additional details available for this product.

Sources

Stay Awake Manufacturers

Chain Drug Marketing Association Inc

Stay Awake | Chain Drug Marketing Association Inc

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Greenbrier International, Inc.

Stay Awake | Greenbrier International, Inc.

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Winco Foods, Llc

Stay Awake | Winco Foods, Llc

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Chain Drug Marketing Association

Stay Awake | Chain Drug Marketing Association

adults and children 12 years of age and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Great Lakes Wholesale, Marketing, & Sales, Inc.

Stay Awake | Great Lakes Wholesale, Marketing, & Sales, Inc.

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Kroger Company

Stay Awake | Kroger Company

adults and children 12 years of age and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Hyvee Inc

Stay Awake | Hyvee Inc

adults and children 12 years of age and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
H E B

Stay Awake | H E B

adults and children 12 years of age and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Rite Aid

Stay Awake | Rite Aid

adults and children 12 years of age and over: take 1/2 to 1 caplet not more often than every 3 to 4 hours

No Recall
Publix Super Markets Inc

Stay Awake | Publix Super Markets Inc

adults and children 12 years of age and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Stephen L. Lafrance Pharmacy, Inc.

Stay Awake | Emd Serono, Inc.

2.1 Dosing Information
The recommended dose of REBIF is either 22 mcg or 44 mcg injected subcutaneously three times per week. REBIF should be administered, if possible, at the same time (preferably in the late afternoon or evening) on the same three days (e.g., Monday, Wednesday, and Friday) at least 48 hours apart each week.

Generally, patients should be started at 20% of the prescribed dose three times per week and increased over a 4-week period to the targeted dose, either 22 mcg three times per week (see Table 1) or 44 mcg three times per week (see Table 2). Patients prescribed a targeted dose of 22 mcg three times per week should use the prefilled syringes for titration.

A Titration Pack containing 6 doses of 8.8 mcg (0.2 mL) and 6 doses of 22 mcg (0.5 mL) is available for use during the titration period in both REBIF prefilled syringes and REBIF Rebidose autoinjectors.
Table 1: Titration Schedule for a 22 mcg Prescribed Dose* Week of Use Dose Syringe to Use Amount of syringe * Use only prefilled syringes, not autoinjectors, to titrate to the 22 mcg Prescribed Dose Week 1 Titration 4.4 mcg 8.8 mcg syringe Use half of syringe Week 2 Titration 4.4 mcg 8.8 mcg syringe Use half of syringe Week 3 Titration 11 mcg 22 mcg syringe Use half of syringe Week 4 Titration 11 mcg 22 mcg syringe Use half of syringe Week 5 and after 22 mcg 22 mcg syringe or autoinjector Use full syringe or autoinjector Table 2: Titration Schedule for a 44 mcg Prescribed Dose* Week of Use Dose Syringe or Autoinjector to Use Amount of syringe or autoinjector * Prefilled syringes or autoinjectors can be used to titrate to the 44 mcg Prescribed Dose Week 1 Titration 8.8 mcg 8.8 mcg syringe or autoinjector Use full syringe or autoinjector Week 2 Titration 8.8 mcg 8.8 mcg syringe or autoinjector Use full syringe or autoinjector Week 3 Titration 22 mcg 22 mcg syringe or autoinjector Use full syringe or autoinjector Week 4 Titration 22 mcg 22 mcg syringe or autoinjector Use full syringe or autoinjector Week 5 and after 44 mcg 44 mcg syringe or autoinjector Use full syringe or autoinjector
Decreased peripheral blood counts or elevated liver function tests may necessitate dose reduction or discontinuation of REBIF administration until toxicity is resolved [see Warnings and Precautions (5.2, 5.5) and Adverse Reactions (6)].
2.2 Important Administration Instructions
REBIF is intended for use under the guidance and supervision of a physician. It is recommended that physicians or qualified medical personnel train patients in the proper technique for self-administering subcutaneous injections using the prefilled syringe or injection device approved for use with REBIF. Injection depth of the REBIF Rebidose autoinjector is fixed at 8 mm; the health care provider should determine the injection technique.

The initial injection should be performed under the supervision of an appropriately qualified health care provider.

Appropriate instruction for self-injection or injection by another person should be provided to the patient or their caregiver, including careful review of the REBIF Medication Guide and the REBIF Rebidose autoinjector Instructions for Use that accompanies the product. Users should demonstrate competency in all aspects of the injection prior to independent use. If a patient is to self-administer REBIF, the physical and cognitive ability of that patient to self-administer and properly dispose of prefilled syringes or the REBIF Rebidose autoinjectors should be assessed. Patients with severe neurological deficits should not self-administer injections without assistance from a trained caregiver.

Advise patients and caregivers to:
visually inspect REBIF for particulate matter and discoloration prior to administration use aseptic technique when administering REBIF rotate site of injection with each dose to minimize the likelihood of severe injection site reactions or necrosis [see Warnings and Precautions, (5.4)] use a puncture-resistant container for safe disposal of used needles, prefilled syringes and REBIF Rebidose autoinjectors do not re-use needles, syringes or REBIF Rebidose autoinjectors 2.3 Premedication for Flu-like Symptoms
Concurrent use of analgesics and/or antipyretics may help ameliorate flu-like symptoms associated with REBIF use on treatment days.

No Recall
Western Family Foods, Inc.

Stay Awake | Western Family Foods, Inc.

adults and children 12 years of age and over: take 1 tablet (200 mg) not more often than every 3 to 4 hours

No Recall
Freds Inc

Stay Awake | Freds Inc

adults and children 12 years of age and over: take 1 tablet (200 mg) not more often than every 3 to 4 hours

No Recall
Army And Air Force Exchange Service

Stay Awake | H E B

• if you are under 18 years of age, ask a doctor before use • before using this product, read the enclosed User’s Guide for complete directions and other important information • begin using the gum on your quit day • if you smoke your first cigarette within 30 minutes of waking up, use Nicotine Polacrilex Gum, 4 mg • if you smoke your first cigarette more than 30 minutes after waking up, use Nicotine Polacrilex Gum, 2 mg according to the following 12 week schedule:
Weeks 1 to 6

Weeks 7 to 9

Weeks 10 to 12

1 piece every

1 to 2 hours

1 piece every

2 to 4 hours

1 piece every

4 to 8 hours
• nicotine gum is a medicine and must be used a certain way to get the best results • chew the gum slowly until it tingles. Then park it between your cheek and gum. When the tingle is gone, begin chewing again, until the tingle returns. • repeat this process until most of the tingle is gone (about 30 minutes) • do not eat or drink for 15 minutes before chewing the nicotine gum, or while chewing a piece • to improve your chances of quitting, use at least 9 pieces per day for the first 6 weeks • if you experience strong or frequent cravings, you may use a second piece within the hour. However, do not continuously use one piece after another since this may cause you hiccups, heartburn, nausea or other side effects. • do not use more than 24 pieces a day • it is important to complete treatment. If you feel you need to use the gum for a longer period to keep from smoking, talk to your health care provider.

No Recall
Wal-mart Stores Inc

Stay Awake | Wal-mart Stores Inc

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Kinray Inc.

Stay Awake | Kinray Inc.

adults and children 12 years of age and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Salado Sales, Inc.

Stay Awake | Novartis Pharmaceuticals Corporation

Myocardial Infarction
Early Treatment: During the early phase of definite or suspected acute myocardial infarction, initiate treatment with Lopressor as soon as possible after the patient’s arrival in the hospital. Such treatment should be initiated in a coronary care or similar unit immediately after the patient’s hemodynamic condition has stabilized.

Begin treatment in this early phase with the intravenous administration of three bolus injections of 5 mg of Lopressor each; give the injections at approximately 2-minute intervals. During the intravenous administration of Lopressor, monitor blood pressure, heart rate, and electrocardiogram.

In patients who tolerate the full intravenous dose (15 mg), initiate Lopressor tablets, 50 mg every 6 hours, 15 minutes after the last intravenous dose and continue for 48 hours. Thereafter, the maintenance dosage is 100 mg orally twice daily.

Start patients who appear not to tolerate the full intravenous dose on Lopressor tablets either 25 mg or 50 mg every 6 hours (depending on the degree of intolerance) 15 minutes after the last intravenous dose or as soon as their clinical condition allows. In patients with severe intolerance, discontinue Lopressor (see WARNINGS).
Special Populations
Pediatric patients: No pediatric studies have been performed. The safety and efficacy of Lopressor in pediatric patients have not been established.

Renal impairment: No dose adjustment of Lopressor is required in patients with renal impairment.

Hepatic impairment: Lopressor blood levels are likely to increase substantially in patients with hepatic impairment. Therefore, Lopressor should be initiated at low doses with cautious gradual dose titration according to clinical response.

Geriatric patients (>65 years): In general, use a low initial starting dose in elderly patients given their greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Method of Administration
Parenteral administration of Lopressor (ampoule) should be done in a setting with intensive monitoring.

Note: Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

No Recall
Nash-finch Company

Stay Awake | Pd-rx Pharmaceuticals, Inc.

THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF DOXYCYCLINE DIFFERS FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS.

Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100 mg every 12 hours or 50 mg every 6 hours) followed by a maintenance dose of 100 mg/day. The maintenance dose may be administered as a single dose or as 50 mg every 12 hours. In the management of more severe infections (particularly chronic infections of the urinary tract), 100 mg every 12 hours is recommended.

For pediatric patients above eight years of age: The recommended dosage schedule for pediatric patients weighing 100 pounds or less is 2 mg/lb of body weight divided into two doses on the first day of treatment, followed by 1 mg/lb of body weight given as a single daily dose or divided into two doses, on subsequent days. For more severe infections up to 2 mg/lb of body weight may be used. For pediatric patients over 100 pounds the usual adult dose should be used.

Uncomplicated gonococcal infections in adults (except anorectal infections in men): 100 mg, by mouth, twice a day for 7 days. As an alternate single visit dose, administer 300 mg stat followed in one hour by a second 300 mg dose.

Acute epididymo-orchitis caused by N. gonorrhoeae: 100 mg, by mouth, twice a day for at least 10 days.

Primary and secondary syphilis: 300 mg a day in divided doses for at least 10 days.

Uncomplicated urethral, endocervical, or rectal infection in adults caused by Chlamydia trachomatis: 100 mg, by mouth, twice a day for at least 7 days.

Nongonococcal urethritis caused by C. trachomatis and U. urealyticum: 100 mg, by mouth, twice a day for at least 7 days.

Acute epididymo-orchitis caused by C. trachomatis: 100 mg, by mouth, twice a day for at least 10 days.

Inhalational anthrax (post-exposure): ADULTS: 100 mg of doxycycline, by mouth, twice a day for 60 days. CHILDREN: weighing less than 100 pounds (45 kg); 1 mg/lb (2.2 mg/kg) of body weight, by mouth, twice a day for 60 days. Children weighing 100 pounds or more should receive the adult dose.

When used in streptococcal infections, therapy should be continued for 10 days.

Administration of adequate amounts of fluid along with capsule and tablet forms of drugs in the tetracycline class is recommended to wash down the drugs and reduce the risk of esophageal irritation and ulceration. (See ADVERSE REACTIONS.) If gastric irritation occurs, doxycycline may be given with food. Ingestion of a high fat meal has been shown to delay the time to peak plasma concentrations by an average of one hour and 20 minutes. However, in the same study, food enhanced the average peak concentration by 7.5% and the area under the curve by 5.7%.

No Recall
Major Pharmaceuticals

Stay Awake | Major Pharmaceuticals

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Supervalu Inc.

Stay Awake | Supervalu Inc.

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Walgreen Co.

Stay Awake | Austin Respiratory Equipment,inc

There is currently no dosage information available for this product. We apologize for any inconvenience.

No Recall
Supervalu Inc.

Stay Awake | Supervalu Inc.

adults and children 12 years of age and over: take 1/2 to 1 caplet not more often than every 3 to 4 hours

No Recall
Western Family Foods, Inc.

Stay Awake | Western Family Foods, Inc.

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Freds Inc

Stay Awake | Freds Inc

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
Best Choice (Valu Merchandisers Company)

Stay Awake | Best Choice (valu Merchandisers Company)

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall
National Distribution Network (Smart Choice)

Stay Awake | National Distribution Network (smart Choice)

adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours

No Recall